Lidocaine Infusion With ANI Monitoring in Spine Surgery.

Launched by KAOHSIUNG MEDICAL UNIVERSITY CHUNG-HO MEMORIAL HOSPITAL · Oct 21, 2021

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a medication called lidocaine, which will be given continuously during spine surgery to help manage pain. Specifically, researchers want to see if using lidocaine along with special monitors that track pain and anesthesia levels can improve recovery for patients undergoing elective lumbar spine surgery. This study is currently looking for participants aged 20 to 80 who are scheduled for this type of surgery and are generally healthy.

If you or a family member are considering joining the trial, it’s important to know that participants will receive lidocaine during their surgery and will be closely monitored to ensure their comfort and safety. However, there are some criteria you must meet to be eligible. For example, participants should not have severe mental health issues, major liver problems, or be pregnant. Additionally, people who are currently using opioids or have certain heart conditions may not be able to participate. This trial aims to enhance recovery after surgery, which means helping patients feel better and get back to their daily lives more quickly.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Twenty to eighty-year-old
• • 2. ASA class I-III patients undergoing
• • 3. Elective lumbar spine surgery under general anesthesia
• Exclusion Criteria:
• • 1. Unable to understand the Numerical Rating Scale (NRS)
• • 2. Severe mental disorder
• • 3. Poor liver function
• • 4. Pregnant or lactating women
• • 5. Morbidly obese
• • 6. History of epilepsy or allergy to any of the drugs used in this study
• • 7. Current use of opioids
• • 8. Baseline heart rate \<50 beats/min
• • 9. Arrhythmia history with cardiac rhythm device
• • 10. Body weight \<40 kg and \>80kg